Monroe Capital SEC Filings

Monroe Capital Corporation declared a fourth quarter distribution of $0.18 per share on its common stock.

The distribution will be paid on December 31, 2025 to stockholders of record as of December 23, 2025, so only holders on that record date will receive this distribution.

Monroe Capital Corporation plans to redeem $130 million aggregate principal of its 4.75% Notes due 2026 on January 15, 2026. The redemption is conditional on completing one or more financing transactions that generate at least $130 million of net proceeds before the redemption date. The company may delay the redemption date, including beyond 60 days after the conditional notices, until the financing is completed. It may also rescind the notice and not redeem the notes if the financing condition is not met. The notes are expected to be redeemed at 100% of their principal amount, plus accrued and unpaid interest through, but excluding, the redemption date.

Monroe Capital Corporation furnished an 8-K announcing its financial results for the third quarter ended September 30, 2025. The company issued a press release, which is included as Exhibit 99.1 and incorporated by reference. The disclosure under Item 2.02 is being furnished and not deemed filed under Section 18 of the Exchange Act. Monroe Capital’s common stock trades on the Nasdaq Global Select Market under the symbol MRCC.

Monroe Capital Corporation announced it will release its financial results for the third quarter ended September 30, 2025 on Wednesday, November 5, 2025, after the close of the financial markets.

The disclosure is provided under Item 7.01 (Regulation FD) and, along with the related press release furnished as Exhibit 99.1, is designated as “furnished” rather than “filed.” The company’s common stock trades on the Nasdaq Global Select Market under the symbol MRCC.

Monroe Capital Corporation (MRCC) reported total assets of $394.6 million at June 30, 2025, down from $490.7 million at December 31, 2024. Investments at fair value declined to $367.7 million from $457.0 million, and total net assets fell to $179.6 million from $191.8 million, producing a net asset value per share of $8.29 versus $8.85 at year-end.

Investment income decreased year-over-year, with total investment income of $9.873 million in Q2 2025 versus $15.627 million in Q2 2024; net investment income was $3.298 million for the quarter (Q2 2024: $6.559 million). For the six months, investment income was $21.511 million (2024: $30.809 million) and net investment income was $7.383 million (2024: $12.029 million). The company generated $88.361 million of net cash from operating activities in the six months, including $104.993 million of proceeds from principal payments and sales, and used cash to repay $118.1 million of debt (debt principal at June 30, 2025: $210.3 million, versus $293.9 million at year-end).

Monroe Capital Corporation reported that it issued a press release announcing its financial results for the quarter ended June 30, 2025. The company furnished that press release as Exhibit 99.1 to this Current Report on Form 8-K and explicitly stated the release is being furnished (not filed) under the Securities Exchange Act, so it is provided for disclosure purposes and is not incorporated by reference into other SEC filings. The Form 8-K names Lewis W. Solimene, Jr. as the signing officer in his roles as Chief Financial Officer and Chief Investment Officer and lists the registrant's principal executive office in Chicago, Illinois. The filing indicates the company’s common stock trades under the ticker MRCC on The Nasdaq Global Select Market.

Monroe Capital Corporation (MRCC) and Horizon Technology Finance Corporation (HRZN) agreed on August 7, 2025 to combine in a two-step transaction in which MRCC will first sell its investment assets to Monroe Capital Income Plus Corporation (MCIP) for cash at fair value and then merge into HRZN.

The exchange of MRCC shares for HRZN shares will use an Exchange Ratio based on each company’s net asset value calculated as of a Determination Date no earlier than 48 hours before closing; no fractional HRZN shares will be issued. Closing is anticipated in the fourth quarter of 2025 and is subject to stockholder approvals, regulatory clearances (including Hart-Scott-Rodino), registration statement effectiveness and other customary conditions. HRZN’s advisor agreed to a $4.0 million fee waiver, paid at $1.0 million per quarter for four quarters, and the agreements include termination fee provisions (approximately $11.0 million and $5.4 million in specified scenarios).